Skip to main content
. 2023 Jan 27;91(2):103–119. doi: 10.1007/s00280-023-04504-z

Fig. 2.

Fig. 2

A schematic representation of the proposed mechanisms underlying pharmacokinetic-based natural product–drug interactions. The illustrations were taken from the Servier Medical Art (SMART, https://smart.servier.com). DME drug-metabolising enzyme, MBI mechanism-based inhibition, NR nuclear receptor, PHC phytochemical, rev ihb reversible inhibition, RM reactive metabolite